Benzinga | Nov 5, 2020 04:25PM EST

Ironwood Pharmaceuticals Q3 EPS $0.23 Beats $0.15 Estimate, Sales $103.47M Beat $95.96M Estimate

Ironwood Pharmaceuticals (NASDAQ:IRWD) reported quarterly earnings of $0.23 per share which beat the analyst consensus estimate of $0.15 by 53.33 percent. This is a 42.5 percent decrease over earnings of $0.40 per share from the same period last year. The company reported quarterly sales of $103.47 million which beat the analyst consensus estimate of $95.96 million by 7.82 percent. This is a 21.12 percent decrease over sales of $131.17 million the same period last year.